And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

PALI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.24%

Insider Buying (Last 12 Months): $34,791.30

Insider Selling (Last 12 Months): $192.00

Palisade Bio Insider Trading History Chart

Palisade Bio Share Price & Price History

^$4.93

▲ +0.22 (4.67%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

Palisade Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/31/2024	Donald Allen Williams	Director	Buy	666	$9.00	$5,994.00	2,000
9/27/2023	Donald Allen Williams	Director	Buy	1,333	$8.10	$10,797.30	1,333
9/27/2023	John David Finley	CEO	Buy	1,000	$8.10	$8,100.00	2,892
9/14/2023	Robert J. Trenschel	Director	Sell	20	$9.60	$192.00
9/13/2023	John David Finley	CEO	Buy	1,000	$9.90	$9,900.00	1,892
8/23/2022	John David Finley	CFO	Buy	490	$2.40	$1,176.00	8,616
8/16/2022	John David Finley	CFO	Buy	6,666	$3.75	$24,997.50	8,126
8/16/2022	Thomas Hallam	CEO	Buy	2,666	$3.75	$9,997.50	3,839
3/29/2022	Michael John Dawson	Insider	Buy	1,000	$17.10	$17,100.00
3/28/2022	Thomas Hallam	CEO	Buy	666	$17.70	$11,788.20
3/24/2022	John David Finley	CFO	Buy	500	$16.35	$8,175.00
9/21/2021	John David Finley	CFO	Buy	133	$36.60	$4,867.80
9/21/2021	Thomas Hallam	CEO	Buy	400	$37.35	$14,940.00
9/9/2021	Robert J Trenschel	Director	Buy	226	$43.35	$9,797.10	116
9/7/2021	Robert J Trenschel	Director	Buy	180	$41.70	$7,506.00
8/31/2021	Robert J. Trenschel	Director	Buy	116	$41.25	$4,785.00	116
8/27/2021	John David Finley	CFO	Buy	666	$39.75	$26,473.50

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

SEC Filings (Institutional Ownership Changes) for Palisade Bio (NASDAQ:PALI)

11.79% of Palisade Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Palisade Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2022	Altium Capital Management LP	5,643,007	$0.56M	0.2%	N/A	25.791%
10/27/2022	Sargent Investment Group LLC	670,000	$76K	0.0%	+179.2%	3.062%
7/26/2022	Sargent Investment Group LLC	240,000	$98K	0.0%	+84.6%	1.097%
2/14/2022	Altium Capital Management LP	333,954	$0.43M	0.1%	N/A	2.460%
11/12/2021	Sargent Investment Group LLC	105,000	$0.28M	0.1%	N/A	0.812%
11/9/2021	BlackRock Inc.	28,841	$76K	0.0%	+16.7%	0.223%
9/17/2021	Virtu Financial LLC	18,200	$74K	0.0%	N/A	0.160%
8/16/2021	State Street Corp	28,210	$0.12M	0.0%	N/A	0.978%
8/16/2021	Sabby Management LLC	52,500	$0.21M	0.0%	N/A	1.821%
8/13/2021	Renaissance Technologies LLC	145,300	$0.59M	0.0%	N/A	5.040%
8/13/2021	Altium Capital Management LP	1,824,894	$7.43M	1.7%	N/A	63.298%
8/13/2021	Geode Capital Management LLC	24,675	$100K	0.0%	N/A	0.856%
8/13/2021	Vanguard Group Inc.	237,811	$0.97M	0.0%	N/A	8.249%
8/12/2021	Private Advisor Group LLC	21,051	$86K	0.0%	N/A	0.730%
8/6/2021	HighTower Advisors LLC	16,666	$68K	0.0%	N/A	0.578%
7/31/2021	Strategic Wealth Designers	53,129	$0.22M	0.1%	N/A	1.845%

Data available starting January 2016

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.

Today's Range

Now: $4.93

$4.66

$5.00

50 Day Range

MA: $5.76

$4.07

$6.74

52 Week Range

Now: $4.93

$3.82

$36.60

Volume

29,004 shs

Average Volume

562,931 shs

Market Capitalization

$4.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Palisade Bio?: Palisade Bio's top insider investors include:
John David Finley (CFO)
Thomas Hallam (CEO)
John David Finley (CEO)
Donald Allen Williams (Director)
Robert J Trenschel (Director)
Learn More about top insider investors at Palisade Bio.

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here